J&J Cultivates Early Stage Science Through A Trio Of Initiatives
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharma opened its California Innovation Center in Menlo Park, announced a planned expansion of its incubator to San Francisco and started a program to help entrepreneurs start new life science companies.
You may also be interested in...
California Dreaming: J&J Builds Bay Area Ties With Second Startup Home
Among other startups selected by J&J, remote-controlled CAR therapy company Driver BioEngineering and neurodegenerative disease specialist Alkahest have secured a home in new South San Francisco incubator, where they can tap into expertise and equipment with “no strings attached.”
J&J’s New Innovation Centers Test Immersion Theory Of Access
Johnson & Johnson executives including Pharma Chairman and CSO Paul Stoffels explain how building a presence in innovation’s backyard will allow the health care giant to more easily and quickly access new assets and technologies. Can proximity to innovation make J&J more innovative?
Backing New Index Fund, GSK, J&J Buy Into Asset-Centric Vision Of Biotech Future
Index Life VI is the first life-sciences-only fund for Index; GSK’s Moncef Slaoui and J&J’s Paul Stoffels are on scientific advisory board.